AN ADAPTIVE, DOSE-EXPLORATION, PHASE 2 TRIAL EVALUATING EFFICACY AND SAFETY OF IPTACOPAN IN COMBINATION WITH STANDARD-OF-CARE WITH AND WITHOUT ORAL CORTICOSTEROIDS IN ACTIVE LUPUS NEPHRITIS
Back
Abstract Number
WCN23-0405
Categories
AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Clinical Glomerulonephritis
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
AN ADAPTIVE, DOSE-EXPLORATION, PHASE 2 TRIAL EVALUATING EFFICACY AND SAFETY OF IPTACOPAN IN COMBINATION WITH STANDARD-OF-CARE WITH AND WITHOUT ORAL CORTICOSTEROIDS IN ACTIVE LUPUS NEPHRITIS
Co-authors
Veldandi, U.K.(1)*;Anders , H.J.(2); Chan, T.M.(3);Jayne, D.(4);Mahajan, P.(5);Linnik, J.(6); Webb, N.J.A.(7);Meier, M.(7);Rovin, B.(8)
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Novartis Healthcare Pvt Ltd, Global Drug Development, Hyderabad, India;(2)University Hospital- Lmu Munich, Medicine Iv, Munich, Germany;(3)University Of Hong Kong, School Of Clinical Medicine, Hong Kong, Hong Kong- China;(4)University Of Cambridge, Medicine, Cambridge, United Kingdom;(5)Novartis Healthcare Pvt Ltd, Gdo-Trial Management, Hyderabad, India;(6)Novartis Pharma Ag, Gdd Biostatistics, Basel, Switzerland;(7)Novartis Pharma Ag, Global Drug Development, Basel, Switzerland;(8)The Ohio State University Wexner Medical Centre, Internal Medicine, Columbus- Ohio, United States
E-Poster
https://storage.unitedwebnetwork.com/files/1041/2704880facdbdb48e431ae7528c76d0c.pdf
Audio File
if any